董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Heng Fai Ambrose Chan | 男 | Director | 81 | 0.40万美元 | 30.00 | 2026-03-11 |
| Frank D. Heuszel | 男 | Chairman of the Board and Chief Executive Officer and Director | 69 | 30.20万美元 | 49.55 | 2026-03-11 |
| Jason Grady | 男 | Director | 52 | 0.50万美元 | 30.02 | 2026-03-11 |
| Elise Brownell | 女 | Director | 72 | 0.50万美元 | 30.00 | 2026-03-11 |
| Melissa Sims | 女 | Director | 57 | 0.50万美元 | 30.00 | 2026-03-11 |
| David Keene | 男 | Director | 68 | 0.50万美元 | 30.00 | 2026-03-11 |
| Christian Zimmerman | 男 | Director | 48 | 0.50万美元 | 30.00 | 2026-03-11 |
| Castel Hibbert | 男 | Director | 67 | 0.50万美元 | 30.00 | 2026-03-11 |
| Chang Heng Fai Ambrose | 男 | Director | 81 | 未披露 | 未持股 | 2026-03-11 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Frank D. Heuszel | 男 | Chairman of the Board and Chief Executive Officer and Director | 69 | 30.20万美元 | 49.55 | 2026-03-11 |
| Todd D. Macko | 男 | Chief Financial Officer | 53 | 0.06万美元 | 20.01 | 2026-03-11 |
| Mark Suseck | 男 | Chief Operating Officer | 65 | 29.38万美元 | 30.00 | 2026-03-11 |
董事简历
中英对照 | 中文 | 英文- Heng Fai Ambrose Chan
-
Heng Fai Ambrose Chan是银行和金融领域的专家，在这些行业拥有45年经验。在过去的40年里，他重组了多个行业和国家的数字公司。陈先生自2013年5月起担任新交所上市公司Alset International Limited的董事，自2014年4月起担任其首席执行官，自2017年6月起担任其董事会主席。Chan先生自2014年10月起担任Hapi Metaverse Inc.董事，自2021年7月起担任董事长。Chan先生自2017年1月起担任Winning Catering Group，Inc.（前身为LiquidValue Development Inc.）的董事，并自2017年12月起担任其董事会主席。Chan先生自2017年1月起担任纽交所上市公司DSS，Inc.的董事，并自2019年3月起担任其董事会主席。Chan先生是Alset Inc.的创始人，该公司为纳斯达克上市公司，为公司的大股东，自2018年3月成立以来一直担任其董事会主席兼首席执行官。Chan先生自2021年12月起担任OTC Markets公司Value Exchange International，Inc.的董事。自2025年3月以来，陈先生一直担任纽交所上市公司Impact BioMedical Inc.的董事。陈先生自2025年6月起担任香港联交所上市公司True Partner Capital Holding Limited的非执行董事。陈先生曾担任中国燃气控股有限公司的执行主席，该公司是一家香港交易所上市公司，1997年至2002年是中国城市燃气管道基础设施的投资者和运营商。Chan先生曾于2005年至2006年担任Atralian航空上市公司Skyst Ltd.的董事。陈先生曾于2003年3月至2013年9月担任新加坡物业发展公司SingHaiyi Group Ltd.（现称SingHaiyi Group Pte.Ltd.）的董事总经理，该公司以前在新交所上市。陈先生曾于1992年9月至2015年担任香港联交所上市公司Heng Fai Enterprises Limited（现称Zensun Enterprises Limited）的董事，并于1995年至2015年担任管理主席。陈先生曾于2013年12月至2015年7月担任Global Medical REIT Inc.的董事，Global Medical REIT Inc.是一家在纽约证券交易所上市的公司，是一家医疗设施房地产公司。陈先生曾于2014年6月至2019年2月担任RSI International Systems，Inc.（现称为ARCpoint Inc.）的董事，该公司是一家TSXV上市公司，是基于b的物业管理系统RoomKeyPMS的开发商。Chan先生于2013年7月至2021年6月期间担任ASX上市公司Holista CollTech Ltd.的董事。Chan先生于2018年6月至2022年4月期间担任合宜银行控股，Inc.的董事。Chan先生于2020年4月至2025年7月担任OTC Markets上市公司Sharing Services Global Corporation的董事，并于2021年7月至2025年7月担任其董事会主席。
Heng Fai Ambrose Chan is an expert in banking and finance, with 45 years of experience in these indtries. He has restructured numero companies in vario indtries and countries during the past 40 years. Mr. Chan has served as a director of Alset International Limited, an SGX listed company, since May 2013, has served as its Chief Executive Officer since April 2014 and has served as its Chairman of the Board since June 2017. Mr. Chan has served as a director of Hapi Metaverse Inc. since October 2014 and as Chairman since July 2021. Mr. Chan has served as a director of Winning Catering Group, Inc. (formerly known as LiquidValue Development Inc.) since January 2017 and has served as its Chairman of the Board since December 2017. Mr. Chan has served as a director of DSS, Inc., an NYSE listed company, since January 2017 and has served as its Chairman of the Board since March 2019. Mr. Chan is the founder of Alset Inc., a Nasdaq listed company, the majority shareholder of the Company and has served as its Chairman of the Board and Chief Executive Officer since its inception in March 2018. Mr. Chan has served as a director of Value Exchange International, Inc., an OTC Markets company, since December 2021. Mr. Chan has served as a director of Impact BioMedical Inc., a NYSE listed company, since March 2025. Mr. Chan has served as a non executive director of True Partner Capital Holding Limited, an HKSE listed company, since June 2025. Mr. Chan was the Executive Chairman of China Gas Holdings Limited, an HKSE listed company, an investor and operator of city gas pipeline infrastructure in China from 1997 to 2002. Mr. Chan served as director of Skyst Ltd., a public Atralian airline company from 2005 to 2006. Mr. Chan was the Managing Director of SingHaiyi Group Ltd. (now known as SingHaiyi Group Pte. Ltd.), a Singapore property development company formerly listed on the SGX, from March 2003 to September 2013. Mr. Chan served as a director of Heng Fai Enterprises Limited (now known as Zensun Enterprises Limited), an HKSE listed company, an investment holding company, from September 1992 to 2015, and as the Managing Chairman from 1995 to 2015. Mr. Chan served as a director of Global Medical REIT Inc., a NYSE listed company, a healthcare facility real estate company, from December 2013 to July 2015. Mr. Chan served as a director of RSI International Systems, Inc. (now known as ARCpoint Inc.), a TSXV listed company, the developer of RoomKeyPMS, a b based property management system, from June 2014 to February 2019. Mr. Chan served as director of Holista CollTech Ltd., an ASX listed company, from July 2013 until June 2021. Mr. Chan served as a director of OptimumBank Holdings, Inc. from June 2018 until April 2022. Mr. Chan served as a director of Sharing Services Global Corporation, an OTC Markets listed company, from April 2020 to July 2025 and served as its Chairman of the Board from July 2021 to July 2025. - Heng Fai Ambrose Chan是银行和金融领域的专家，在这些行业拥有45年经验。在过去的40年里，他重组了多个行业和国家的数字公司。陈先生自2013年5月起担任新交所上市公司Alset International Limited的董事，自2014年4月起担任其首席执行官，自2017年6月起担任其董事会主席。Chan先生自2014年10月起担任Hapi Metaverse Inc.董事，自2021年7月起担任董事长。Chan先生自2017年1月起担任Winning Catering Group，Inc.（前身为LiquidValue Development Inc.）的董事，并自2017年12月起担任其董事会主席。Chan先生自2017年1月起担任纽交所上市公司DSS，Inc.的董事，并自2019年3月起担任其董事会主席。Chan先生是Alset Inc.的创始人，该公司为纳斯达克上市公司，为公司的大股东，自2018年3月成立以来一直担任其董事会主席兼首席执行官。Chan先生自2021年12月起担任OTC Markets公司Value Exchange International，Inc.的董事。自2025年3月以来，陈先生一直担任纽交所上市公司Impact BioMedical Inc.的董事。陈先生自2025年6月起担任香港联交所上市公司True Partner Capital Holding Limited的非执行董事。陈先生曾担任中国燃气控股有限公司的执行主席，该公司是一家香港交易所上市公司，1997年至2002年是中国城市燃气管道基础设施的投资者和运营商。Chan先生曾于2005年至2006年担任Atralian航空上市公司Skyst Ltd.的董事。陈先生曾于2003年3月至2013年9月担任新加坡物业发展公司SingHaiyi Group Ltd.（现称SingHaiyi Group Pte.Ltd.）的董事总经理，该公司以前在新交所上市。陈先生曾于1992年9月至2015年担任香港联交所上市公司Heng Fai Enterprises Limited（现称Zensun Enterprises Limited）的董事，并于1995年至2015年担任管理主席。陈先生曾于2013年12月至2015年7月担任Global Medical REIT Inc.的董事，Global Medical REIT Inc.是一家在纽约证券交易所上市的公司，是一家医疗设施房地产公司。陈先生曾于2014年6月至2019年2月担任RSI International Systems，Inc.（现称为ARCpoint Inc.）的董事，该公司是一家TSXV上市公司，是基于b的物业管理系统RoomKeyPMS的开发商。Chan先生于2013年7月至2021年6月期间担任ASX上市公司Holista CollTech Ltd.的董事。Chan先生于2018年6月至2022年4月期间担任合宜银行控股，Inc.的董事。Chan先生于2020年4月至2025年7月担任OTC Markets上市公司Sharing Services Global Corporation的董事，并于2021年7月至2025年7月担任其董事会主席。
- Heng Fai Ambrose Chan is an expert in banking and finance, with 45 years of experience in these indtries. He has restructured numero companies in vario indtries and countries during the past 40 years. Mr. Chan has served as a director of Alset International Limited, an SGX listed company, since May 2013, has served as its Chief Executive Officer since April 2014 and has served as its Chairman of the Board since June 2017. Mr. Chan has served as a director of Hapi Metaverse Inc. since October 2014 and as Chairman since July 2021. Mr. Chan has served as a director of Winning Catering Group, Inc. (formerly known as LiquidValue Development Inc.) since January 2017 and has served as its Chairman of the Board since December 2017. Mr. Chan has served as a director of DSS, Inc., an NYSE listed company, since January 2017 and has served as its Chairman of the Board since March 2019. Mr. Chan is the founder of Alset Inc., a Nasdaq listed company, the majority shareholder of the Company and has served as its Chairman of the Board and Chief Executive Officer since its inception in March 2018. Mr. Chan has served as a director of Value Exchange International, Inc., an OTC Markets company, since December 2021. Mr. Chan has served as a director of Impact BioMedical Inc., a NYSE listed company, since March 2025. Mr. Chan has served as a non executive director of True Partner Capital Holding Limited, an HKSE listed company, since June 2025. Mr. Chan was the Executive Chairman of China Gas Holdings Limited, an HKSE listed company, an investor and operator of city gas pipeline infrastructure in China from 1997 to 2002. Mr. Chan served as director of Skyst Ltd., a public Atralian airline company from 2005 to 2006. Mr. Chan was the Managing Director of SingHaiyi Group Ltd. (now known as SingHaiyi Group Pte. Ltd.), a Singapore property development company formerly listed on the SGX, from March 2003 to September 2013. Mr. Chan served as a director of Heng Fai Enterprises Limited (now known as Zensun Enterprises Limited), an HKSE listed company, an investment holding company, from September 1992 to 2015, and as the Managing Chairman from 1995 to 2015. Mr. Chan served as a director of Global Medical REIT Inc., a NYSE listed company, a healthcare facility real estate company, from December 2013 to July 2015. Mr. Chan served as a director of RSI International Systems, Inc. (now known as ARCpoint Inc.), a TSXV listed company, the developer of RoomKeyPMS, a b based property management system, from June 2014 to February 2019. Mr. Chan served as director of Holista CollTech Ltd., an ASX listed company, from July 2013 until June 2021. Mr. Chan served as a director of OptimumBank Holdings, Inc. from June 2018 until April 2022. Mr. Chan served as a director of Sharing Services Global Corporation, an OTC Markets listed company, from April 2020 to July 2025 and served as its Chairman of the Board from July 2021 to July 2025.
- Frank D. Heuszel
-
FrankD.Heuszel自2018年7月30日起担任公司董事，并于2018年7月至2019年4月担任公司审计委员会主席。截至2020年10月28日，他自2019年4月17日起担任公司首席执行官兼临时首席财务官。从那时起，他只担任公司的首席执行官和董事，由于他的执行管理、教育和运营经验，他在多个行业的广泛的战略、业务、周转和监管事务方面拥有丰富的专业知识。在加入DSS之前，Heuszel先生在商业银行有着非常成功的职业生涯。在超过35年的时间里，Heuszel在主要的美国和国际银行组织担任许多高级执行职位。作为一名银行家，Heuszel先生曾担任总法律顾问、特殊资产总监、信贷官、首席财务官和审计员。Heuszel先生还经营着一家成功的法律事务所，专注于诉讼，公司重组，并购和收款。除了是一名律师和执行经理，Heuszel先生还是一名退休的注册会计师，以及一名注册内部审计师。Heuszel先生毕业于德克萨斯大学奥斯汀分校（University of Texas at Austin）和休斯顿南德克萨斯法学院（South Texas College of Law）。
Frank D. Heuszel has served as a member of Impact's board of directors since 2020 and served as the company's President until the 2025 promotion. Prior to becoming the CEO of Impact, Mr. Heuszel served as the Chief Executive Officer of DSS, Inc. ("DSS"), a NYSE:American publicly traded company. In that role he managed the strategic direction, growth, day to day operations, and governance of the New York based multinational company operating binesses in biohealth and bioscience, healthcare, securities trading and management platforms, blockchain technology, direct marketing, real estate, alternative energy, brand protection technology and securitized digital assets, with offices in Hoton, Tx., and W. Henreitta, NY. Mr. Heuszel became DSS's Chief Executive Officer and Interim Chief Financial Officer in April 2019. He served as a member of DSS's board of directors from July 2018 until his resignation in Augt 2024 that allod him to spearhead Impact BioMedical's growth and IPO. Heuszel has extensive expertise in a wide array of strategic, biness, turnaround, and regulatory matters across several indtries as a result of his executive management, educational, and operational experience. Prior to joining DSS, Mr. Heuszel had a very successful career in commercial banking. For over 40+ years, Heuszel served in many senior executive roles with major and international banking organizations. As a banker, Mr. Heuszel has served as General Counsel, Director of Special Assets, Senior Credit Officer, Chief Financial Officer, Controller, Senior Lender, and Director of Internal Audit. Mr. Heuszel also operates a successful law practice foced on the regulation and operation of banks, management of bank litigation, corporate restructurings, and mergers and acquisitions. In addition to being an attorney and executive manager, Mr. Heuszel is also a Certified Public Accountant (retired), and a Certified Internal Auditor (retired), and Certified Trt and Financial Advisor. Mr. Heuszel also currently serves as a director of a Texas community bank, Herring Bank of Amarillo, Texas since May 2022, where he serves upon several Board Committees, including the Audit Committee which he is the Chairman. He also serves on the Board of Herring Bancorp, Inc., where he also serves on multiple board committees, including Chair of the Audit Committee. Frank D. Heuszel was born in Branson, Missi, graduated from the University of Texas at Atin from the McCombs School of Biness in 1979 and received his Doctor of Jurisprudence with honors from South Texas College of Law in 1990. Frank received his certification as a Certified Public Accountant and as a Certified Internal Auditor in 1985 and certified as Certified Trt and Financial Advisor (CTFA) in 2025. Mr. Heuszel is also a member of the Texas State Bar, the Hoton Bar Association, and the State Bar of Texas Bankruptcy Section. - FrankD.Heuszel自2018年7月30日起担任公司董事，并于2018年7月至2019年4月担任公司审计委员会主席。截至2020年10月28日，他自2019年4月17日起担任公司首席执行官兼临时首席财务官。从那时起，他只担任公司的首席执行官和董事，由于他的执行管理、教育和运营经验，他在多个行业的广泛的战略、业务、周转和监管事务方面拥有丰富的专业知识。在加入DSS之前，Heuszel先生在商业银行有着非常成功的职业生涯。在超过35年的时间里，Heuszel在主要的美国和国际银行组织担任许多高级执行职位。作为一名银行家，Heuszel先生曾担任总法律顾问、特殊资产总监、信贷官、首席财务官和审计员。Heuszel先生还经营着一家成功的法律事务所，专注于诉讼，公司重组，并购和收款。除了是一名律师和执行经理，Heuszel先生还是一名退休的注册会计师，以及一名注册内部审计师。Heuszel先生毕业于德克萨斯大学奥斯汀分校（University of Texas at Austin）和休斯顿南德克萨斯法学院（South Texas College of Law）。
- Frank D. Heuszel has served as a member of Impact's board of directors since 2020 and served as the company's President until the 2025 promotion. Prior to becoming the CEO of Impact, Mr. Heuszel served as the Chief Executive Officer of DSS, Inc. ("DSS"), a NYSE:American publicly traded company. In that role he managed the strategic direction, growth, day to day operations, and governance of the New York based multinational company operating binesses in biohealth and bioscience, healthcare, securities trading and management platforms, blockchain technology, direct marketing, real estate, alternative energy, brand protection technology and securitized digital assets, with offices in Hoton, Tx., and W. Henreitta, NY. Mr. Heuszel became DSS's Chief Executive Officer and Interim Chief Financial Officer in April 2019. He served as a member of DSS's board of directors from July 2018 until his resignation in Augt 2024 that allod him to spearhead Impact BioMedical's growth and IPO. Heuszel has extensive expertise in a wide array of strategic, biness, turnaround, and regulatory matters across several indtries as a result of his executive management, educational, and operational experience. Prior to joining DSS, Mr. Heuszel had a very successful career in commercial banking. For over 40+ years, Heuszel served in many senior executive roles with major and international banking organizations. As a banker, Mr. Heuszel has served as General Counsel, Director of Special Assets, Senior Credit Officer, Chief Financial Officer, Controller, Senior Lender, and Director of Internal Audit. Mr. Heuszel also operates a successful law practice foced on the regulation and operation of banks, management of bank litigation, corporate restructurings, and mergers and acquisitions. In addition to being an attorney and executive manager, Mr. Heuszel is also a Certified Public Accountant (retired), and a Certified Internal Auditor (retired), and Certified Trt and Financial Advisor. Mr. Heuszel also currently serves as a director of a Texas community bank, Herring Bank of Amarillo, Texas since May 2022, where he serves upon several Board Committees, including the Audit Committee which he is the Chairman. He also serves on the Board of Herring Bancorp, Inc., where he also serves on multiple board committees, including Chair of the Audit Committee. Frank D. Heuszel was born in Branson, Missi, graduated from the University of Texas at Atin from the McCombs School of Biness in 1979 and received his Doctor of Jurisprudence with honors from South Texas College of Law in 1990. Frank received his certification as a Certified Public Accountant and as a Certified Internal Auditor in 1985 and certified as Certified Trt and Financial Advisor (CTFA) in 2025. Mr. Heuszel is also a member of the Texas State Bar, the Hoton Bar Association, and the State Bar of Texas Bankruptcy Section.
- Jason Grady
-
Jason Grady自2019年8月起担任公司首席运营官，自2018年7月起，Grady先生还担任Premier Packaging Corporation的总裁，该公司是一家多部门折叠纸箱和安全包装公司，也是该公司的全资子公司。从2010年4月到2018年7月，格雷迪先生担任公司的销售Vice President。作为首席运营官，格雷迪先生的职责包括多个部门的运营管理，为公司每个新成立的子公司的方向提供建议，并对各种业务运营中的新兴市场机会进行研究与开发。Grady先生的角色包括战略领导和驱动关键举措，其中包括重新设计销售组织，新业务开发，国际销售，销售管理和企业营销。他曾负责多部门销售的整体管理，包括防伪&认证解决方案、企业安全软件技术和文档安全打印。在DSS获得成功之前，Grady先生曾担任Parlec Corporation（一家多市场机床制造商）的市场营销Vice President，并担任柏林包装公司（Berlin Packaging Corporation）的业务开发总监，该公司是一家定制脊形盒子和折叠纸盒制造商，并担任Outstart，Inc.（一家企业电子学习软件公司）销售与市场营销主管。Grady先生在罗彻斯特理工学院（Rochester Institute of Technology）获得营销与传播本科学位和工商管理硕士学位。
Jason Grady has served as Interim Chief Executive Officer of DSS, Inc since October 2024. He is a seasoned executive recognized for his expertise in turnaround management, executive leadership, corporate strategy, and disciplined shareholder communication. In his role as CEO, Mr. Grady is responsible for setting strategic direction, driving operational and financial performance, and aligning leadership execution with long term value creation. He works closely with the Board of Directors, investors, and strategic partners, with a foc on accountability, capital discipline, and stainable profitability across the enterprise. Prior to assuming the CEO role, Mr. Grady served as Chief Operating Officer since Augt 2019, where he led enterprise wide operational restructuring, improved cost discipline, and enhanced execution across a diversified portfolio of binesses. His tenure as COO was marked by hands on leadership, performance based management systems, and a strong emphasis on transparency and results. Since July 2018, Mr. Grady has also served as President and CEO of Premier Packaging Corporation, a world class folding carton and consumer packaging manufacturer. Under his leadership, Premier has strengthened its operational foundation, expanded into higher value end markets, and reinforced a quality first, ctomer centric culture. His impact across the broader DSS platform has been central to improving operational rigor and strategic foc. From April 2010 to July 2018, Mr. Grady served as Vice President of Sales and Biness Development, where he was instrumental in driving revenue growth, expanding key ctomer relationships, and positioning the Company for long term expansion. Before joining DSS, Mr. Grady held senior leadership roles including Vice President of Marketing at Parlec Corporation, Director of Biness Development at Berlin Packaging Corporation, and sales and marketing leadership positions at OutStart, Inc. Mr. Grady holds a bachelor's degree in marketing and communications and an Masters of Biness Administration (MBA) from the Rochester Institute of Technology. - Jason Grady自2019年8月起担任公司首席运营官，自2018年7月起，Grady先生还担任Premier Packaging Corporation的总裁，该公司是一家多部门折叠纸箱和安全包装公司，也是该公司的全资子公司。从2010年4月到2018年7月，格雷迪先生担任公司的销售Vice President。作为首席运营官，格雷迪先生的职责包括多个部门的运营管理，为公司每个新成立的子公司的方向提供建议，并对各种业务运营中的新兴市场机会进行研究与开发。Grady先生的角色包括战略领导和驱动关键举措，其中包括重新设计销售组织，新业务开发，国际销售，销售管理和企业营销。他曾负责多部门销售的整体管理，包括防伪&认证解决方案、企业安全软件技术和文档安全打印。在DSS获得成功之前，Grady先生曾担任Parlec Corporation（一家多市场机床制造商）的市场营销Vice President，并担任柏林包装公司（Berlin Packaging Corporation）的业务开发总监，该公司是一家定制脊形盒子和折叠纸盒制造商，并担任Outstart，Inc.（一家企业电子学习软件公司）销售与市场营销主管。Grady先生在罗彻斯特理工学院（Rochester Institute of Technology）获得营销与传播本科学位和工商管理硕士学位。
- Jason Grady has served as Interim Chief Executive Officer of DSS, Inc since October 2024. He is a seasoned executive recognized for his expertise in turnaround management, executive leadership, corporate strategy, and disciplined shareholder communication. In his role as CEO, Mr. Grady is responsible for setting strategic direction, driving operational and financial performance, and aligning leadership execution with long term value creation. He works closely with the Board of Directors, investors, and strategic partners, with a foc on accountability, capital discipline, and stainable profitability across the enterprise. Prior to assuming the CEO role, Mr. Grady served as Chief Operating Officer since Augt 2019, where he led enterprise wide operational restructuring, improved cost discipline, and enhanced execution across a diversified portfolio of binesses. His tenure as COO was marked by hands on leadership, performance based management systems, and a strong emphasis on transparency and results. Since July 2018, Mr. Grady has also served as President and CEO of Premier Packaging Corporation, a world class folding carton and consumer packaging manufacturer. Under his leadership, Premier has strengthened its operational foundation, expanded into higher value end markets, and reinforced a quality first, ctomer centric culture. His impact across the broader DSS platform has been central to improving operational rigor and strategic foc. From April 2010 to July 2018, Mr. Grady served as Vice President of Sales and Biness Development, where he was instrumental in driving revenue growth, expanding key ctomer relationships, and positioning the Company for long term expansion. Before joining DSS, Mr. Grady held senior leadership roles including Vice President of Marketing at Parlec Corporation, Director of Biness Development at Berlin Packaging Corporation, and sales and marketing leadership positions at OutStart, Inc. Mr. Grady holds a bachelor's degree in marketing and communications and an Masters of Biness Administration (MBA) from the Rochester Institute of Technology.
- Elise Brownell
-
Elise Brownell，自2021年1月起担任公司董事。Brownell博士拥有20多年的生物技术和制药项目管理经验，在通过临床开发推进项目方面有着良好的记录。她是ASTIA的生命科学创业顾问，ASTIA是美国首屈一指的专注于女性主导企业的创业组织。Brownell博士还是Contract Pharma杂志编辑顾问委员会的成员，曾担任Leaders Network Women in Consulting项目的主席。她是ZephyrBiotech，LLC的联合创始人，ZephyrBiotech，LLC是一家项目管理公司，致力于将治疗候选药物通过开发推向客户的关键转折点。早些时候，布朗内尔博士是Aerovance，Inc.的创始成员、项目管理主管和高级总监。Aerovance，Inc.是一家由风险投资支持的生物技术公司，从拜耳医疗集团分拆出来。在那里，她创建并管理有效的团队流程，将候选产品带入全面的临床1期和2期开发。在加入Aerovance之前，Brownell博士曾担任拜耳生物技术部门的项目管理主管，负责整合项目战略，以满足治疗和市场需求。其他角色包括与第三方建立和谈判伙伴关系以支持开发项目，领导研究团队完成从实验室到诊所的早期开发阶段，以及天使论坛的创业投资经验。布朗内尔博士在耶鲁大学获得生物学硕士、哲学硕士和博士学位，在阿勒格尼学院获得生物学学士学位。
Elise Brownell has served as a director of the Company since January 2021. Dr. Brownell has more than 30 years of biotechnology and pharmaceutical project management experience with a proven track record of advancing programs through clinical development. She serves as a Life Sciences entrepreneurial advisor for ASTIA, the nation's premier entrepreneurial organization foced on women led binesses. Dr. Brownell is also a member of the Editorial Advisory Board for Contract Pharma Magazine, and previo Chair of the Leaders Network program of Women in Consulting. She is the co founder of ZephyrBiotech, LLC, a project management firm dedicated to advancing therapeutic candidates through development to key inflection points for clients. Earlier, Dr. Brownell was a founding member, head of project management and senior director of Aerovance, Inc., a venture backed biotechnology company spun out from Bayer Healthcare, where she created and managed effective team processes to bring product candidates into full scale clinical Phase 1 and 2 developments. Prior to Aerovance, Dr. Brownell acted as head of project management for Bayer's Biotechnology Unit, where she integrated project strategies to meet therapeutic and market needs. Other roles included building and negotiating partnerships with third parties to support development programs, leading research teams through early bench to clinic development phases, as ll as entrepreneurial investment experience with Angel's Forum and How Women Invest. Dr. Brownell received her M.S., M.Phil. and Ph.D. degrees in biology from Yale University and her B.S. degree in biology from Allegheny College. - Elise Brownell，自2021年1月起担任公司董事。Brownell博士拥有20多年的生物技术和制药项目管理经验，在通过临床开发推进项目方面有着良好的记录。她是ASTIA的生命科学创业顾问，ASTIA是美国首屈一指的专注于女性主导企业的创业组织。Brownell博士还是Contract Pharma杂志编辑顾问委员会的成员，曾担任Leaders Network Women in Consulting项目的主席。她是ZephyrBiotech，LLC的联合创始人，ZephyrBiotech，LLC是一家项目管理公司，致力于将治疗候选药物通过开发推向客户的关键转折点。早些时候，布朗内尔博士是Aerovance，Inc.的创始成员、项目管理主管和高级总监。Aerovance，Inc.是一家由风险投资支持的生物技术公司，从拜耳医疗集团分拆出来。在那里，她创建并管理有效的团队流程，将候选产品带入全面的临床1期和2期开发。在加入Aerovance之前，Brownell博士曾担任拜耳生物技术部门的项目管理主管，负责整合项目战略，以满足治疗和市场需求。其他角色包括与第三方建立和谈判伙伴关系以支持开发项目，领导研究团队完成从实验室到诊所的早期开发阶段，以及天使论坛的创业投资经验。布朗内尔博士在耶鲁大学获得生物学硕士、哲学硕士和博士学位，在阿勒格尼学院获得生物学学士学位。
- Elise Brownell has served as a director of the Company since January 2021. Dr. Brownell has more than 30 years of biotechnology and pharmaceutical project management experience with a proven track record of advancing programs through clinical development. She serves as a Life Sciences entrepreneurial advisor for ASTIA, the nation's premier entrepreneurial organization foced on women led binesses. Dr. Brownell is also a member of the Editorial Advisory Board for Contract Pharma Magazine, and previo Chair of the Leaders Network program of Women in Consulting. She is the co founder of ZephyrBiotech, LLC, a project management firm dedicated to advancing therapeutic candidates through development to key inflection points for clients. Earlier, Dr. Brownell was a founding member, head of project management and senior director of Aerovance, Inc., a venture backed biotechnology company spun out from Bayer Healthcare, where she created and managed effective team processes to bring product candidates into full scale clinical Phase 1 and 2 developments. Prior to Aerovance, Dr. Brownell acted as head of project management for Bayer's Biotechnology Unit, where she integrated project strategies to meet therapeutic and market needs. Other roles included building and negotiating partnerships with third parties to support development programs, leading research teams through early bench to clinic development phases, as ll as entrepreneurial investment experience with Angel's Forum and How Women Invest. Dr. Brownell received her M.S., M.Phil. and Ph.D. degrees in biology from Yale University and her B.S. degree in biology from Allegheny College.
- Melissa Sims
-
Melissa Sims，自2023年5月起担任公司董事。西姆斯女士是一名伊利诺伊州执业律师，自1995年以来一直从事法律工作。从北伊利诺伊大学法学院毕业后，Sims女士开始在银行、医疗保健、房地产、刑事、解散、市政和州和上诉法院的遗嘱认证事务中代表客户从事法律的一般业务。2006年，她代表伊利诺伊州德普村处理超级基金遗留污染问题，并在第七巡回上诉法院开创了全国先例。2021年，美国最高法院在Atlantic Richfield v. Christian案中引用了德普村诉埃克森美孚一案作为先例。从2017年8月开始，西姆斯受雇于国际律师事务所Milberg Coleman Bryson Phillps Grossman，PLLC，最近在俄亥俄州北区的国家阿片类药物多区诉讼中代表客户。她还在州、联邦和上诉法院的侵权诉讼中代表全国各地的市政当局。
Melissa Sims has served as a director of the Company since May 2023. Ms. Sims is an Illinois licensed attorney having practiced law since 1995. Following graduation from Northern Illinois University College of Law, Ms. Sims started the general practice of law representing clients in banking, health care, real estate, criminal, dissolution, municipal and probate matters in state and appellate cts. In 2006, she represented the Village of DePue, Illinois regarding legacy pollution from a Superfund site and set national precedent before the Ct of Appeals for the Seventh Circuit. In 2021, the United States Supreme Ct cited the Village of DePue v. ExxonMobil as precedent in the Atlantic Richfield v. Christian case. Starting in August of 2017, Ms. Sims has been employed with Milberg PLLC, where she currently serves as Senior Counsel. She has represented clients in some of the top class action and mass tort lawsuits in the country, including her work in the National Opioid multidistrict litigation in the Northern District of Ohio. She also represents municipalities across the country in tort actions in state, federal and appellate cts. In 2023, Ms. Sims was named to TIME magazine's Top 100 Climate Influencers list in recognition of her leadership in environmental jtice and climate related litigation. - Melissa Sims，自2023年5月起担任公司董事。西姆斯女士是一名伊利诺伊州执业律师，自1995年以来一直从事法律工作。从北伊利诺伊大学法学院毕业后，Sims女士开始在银行、医疗保健、房地产、刑事、解散、市政和州和上诉法院的遗嘱认证事务中代表客户从事法律的一般业务。2006年，她代表伊利诺伊州德普村处理超级基金遗留污染问题，并在第七巡回上诉法院开创了全国先例。2021年，美国最高法院在Atlantic Richfield v. Christian案中引用了德普村诉埃克森美孚一案作为先例。从2017年8月开始，西姆斯受雇于国际律师事务所Milberg Coleman Bryson Phillps Grossman，PLLC，最近在俄亥俄州北区的国家阿片类药物多区诉讼中代表客户。她还在州、联邦和上诉法院的侵权诉讼中代表全国各地的市政当局。
- Melissa Sims has served as a director of the Company since May 2023. Ms. Sims is an Illinois licensed attorney having practiced law since 1995. Following graduation from Northern Illinois University College of Law, Ms. Sims started the general practice of law representing clients in banking, health care, real estate, criminal, dissolution, municipal and probate matters in state and appellate cts. In 2006, she represented the Village of DePue, Illinois regarding legacy pollution from a Superfund site and set national precedent before the Ct of Appeals for the Seventh Circuit. In 2021, the United States Supreme Ct cited the Village of DePue v. ExxonMobil as precedent in the Atlantic Richfield v. Christian case. Starting in August of 2017, Ms. Sims has been employed with Milberg PLLC, where she currently serves as Senior Counsel. She has represented clients in some of the top class action and mass tort lawsuits in the country, including her work in the National Opioid multidistrict litigation in the Northern District of Ohio. She also represents municipalities across the country in tort actions in state, federal and appellate cts. In 2023, Ms. Sims was named to TIME magazine's Top 100 Climate Influencers list in recognition of her leadership in environmental jtice and climate related litigation.
- David Keene
-
David Keene是一名执行级别的银行家，拥有44年的商业银行经验，在社区和区域银行环境中的信用风险管理的各个方面逐步承担责任。目前，基恩担任Unity National Bank的首席信贷官；他自2022年9月起担任该职位。作为首席信贷官，他负责监督贷款政策、收款、贷款操作、信贷管理，以及所有信贷承销和分析、问题贷款解决。2018年5月至2022年9月，基恩在德克萨斯州休斯顿的德克萨斯社区银行担任高级信用风险官。在这个职位上，他的职责之一是为高净值个人、合伙企业和公司的信贷承销提供支持。Keene先生于1979年获得贝勒大学工商管理学士学位。
David Keene is an executive level banker with 45 years of commercial banking experience with progressive responsibilities in all facets of credit risk management in both community and regional bank environments. Mr. Keene is currently retired as of late 2024. He was the chief credit officer of Unity National Bank, the only minority owned bank in Texas; a position he has held since September 2022. As chief credit officer, he oversaw loan policy compliance, loan collections, loan operations, credit administration, and all credit underwriting and analysis, problem loan workouts. From May 2018 to September 2022, Mr. Keene was a senior credit risk officer at Community Bank of Texas in Hoton, Texas. In this position, he was, among other tasks, responsible for the support of the credit underwriting of high net worth individuals, partnerships, and companies. Mr. Keene received a Bachelor of Biness Administration degree from Baylor University in 1979. He majored in both economics and finance. - David Keene是一名执行级别的银行家，拥有44年的商业银行经验，在社区和区域银行环境中的信用风险管理的各个方面逐步承担责任。目前，基恩担任Unity National Bank的首席信贷官；他自2022年9月起担任该职位。作为首席信贷官，他负责监督贷款政策、收款、贷款操作、信贷管理，以及所有信贷承销和分析、问题贷款解决。2018年5月至2022年9月，基恩在德克萨斯州休斯顿的德克萨斯社区银行担任高级信用风险官。在这个职位上，他的职责之一是为高净值个人、合伙企业和公司的信贷承销提供支持。Keene先生于1979年获得贝勒大学工商管理学士学位。
- David Keene is an executive level banker with 45 years of commercial banking experience with progressive responsibilities in all facets of credit risk management in both community and regional bank environments. Mr. Keene is currently retired as of late 2024. He was the chief credit officer of Unity National Bank, the only minority owned bank in Texas; a position he has held since September 2022. As chief credit officer, he oversaw loan policy compliance, loan collections, loan operations, credit administration, and all credit underwriting and analysis, problem loan workouts. From May 2018 to September 2022, Mr. Keene was a senior credit risk officer at Community Bank of Texas in Hoton, Texas. In this position, he was, among other tasks, responsible for the support of the credit underwriting of high net worth individuals, partnerships, and companies. Mr. Keene received a Bachelor of Biness Administration degree from Baylor University in 1979. He majored in both economics and finance.
- Christian Zimmerman
-
Christian Zimmerman，现任SSB Keystone Bank执行副总裁兼首席财务官。齐默尔曼先生自2019年4月起担任这一职务。在这一职位上，齐默尔曼先生除其他任务外，负责审查和编写月度、季度和年终财务报告。从2015年12月到2019年4月，齐默尔曼担任德克萨斯州社区银行的执行副总裁兼财务总监，除其他职责外，他还负责该银行及其控股公司的监管报告，以及编制财务报告。齐默尔曼参与了这家控股公司的首次公开发行，专注于财务报表和分析。Zimmerman先生是一名注册会计师，在德克萨斯大学奥斯汀分校获得工商管理学士学位和专业会计硕士学位。
Christian Zimmerman is currently an accounting executive with Third Coast Bank ("TCB"), focing on merger related items. Prior to joining Third Coast Bank, Mr. Zimmerman served as the executive vice president—chief financial officer of Keystone Bank, SSB, from April 2019 until its merger into TCB. In that role, he revied and prepared monthly, quarterly, and year end financial reports. From December 2015 to April 2019, Mr. Zimmerman was the executive vice president—controller of Community Bank of Texas, N.A., where he managed regulatory reporting for the bank and its holding company and prepared financial reports. He also worked on the holding company's initial public offering, focing on financial statements and analysis. Mr. Zimmerman is a certified public accountant and earned both a Bachelor of Biness Administration and a Master's degree in Professional Accounting from the University of Texas at Atin. - Christian Zimmerman，现任SSB Keystone Bank执行副总裁兼首席财务官。齐默尔曼先生自2019年4月起担任这一职务。在这一职位上，齐默尔曼先生除其他任务外，负责审查和编写月度、季度和年终财务报告。从2015年12月到2019年4月，齐默尔曼担任德克萨斯州社区银行的执行副总裁兼财务总监，除其他职责外，他还负责该银行及其控股公司的监管报告，以及编制财务报告。齐默尔曼参与了这家控股公司的首次公开发行，专注于财务报表和分析。Zimmerman先生是一名注册会计师，在德克萨斯大学奥斯汀分校获得工商管理学士学位和专业会计硕士学位。
- Christian Zimmerman is currently an accounting executive with Third Coast Bank ("TCB"), focing on merger related items. Prior to joining Third Coast Bank, Mr. Zimmerman served as the executive vice president—chief financial officer of Keystone Bank, SSB, from April 2019 until its merger into TCB. In that role, he revied and prepared monthly, quarterly, and year end financial reports. From December 2015 to April 2019, Mr. Zimmerman was the executive vice president—controller of Community Bank of Texas, N.A., where he managed regulatory reporting for the bank and its holding company and prepared financial reports. He also worked on the holding company's initial public offering, focing on financial statements and analysis. Mr. Zimmerman is a certified public accountant and earned both a Bachelor of Biness Administration and a Master's degree in Professional Accounting from the University of Texas at Atin.
- Castel Hibbert
-
Castel Hibbert，从事企业银行业务已有39年，担任过各种管理、承销和业务职责。自2011年8月以来，希伯特先生一直担任Veritex社区银行的执行副总裁兼董事总经理。他目前与中上市场的公司合作，这些公司的年收入从7500万美元到8亿美元不等。Hibbert先生于1981年获得密歇根州立大学雇员关系理学学士学位，并于1983年获得德克萨斯大学奥斯汀分校工商管理硕士学位。
Castel Hibbert retired as an EVP and Managing Director from Veritex Bank after 41 years in Corporate Banking. During his long tenure he held vario management, underwriting and line responsibilities including managing a $250 million portfolio. Mr. Hibbert currently serves as the CFO of a non profit organization. Mr. Hibbert received a Bachelor of Science degree in Employee Relations from Michigan State University in 1981 and a Master in Biness Administration degree from the University of Texas at Atin in 1983. - Castel Hibbert，从事企业银行业务已有39年，担任过各种管理、承销和业务职责。自2011年8月以来，希伯特先生一直担任Veritex社区银行的执行副总裁兼董事总经理。他目前与中上市场的公司合作，这些公司的年收入从7500万美元到8亿美元不等。Hibbert先生于1981年获得密歇根州立大学雇员关系理学学士学位，并于1983年获得德克萨斯大学奥斯汀分校工商管理硕士学位。
- Castel Hibbert retired as an EVP and Managing Director from Veritex Bank after 41 years in Corporate Banking. During his long tenure he held vario management, underwriting and line responsibilities including managing a $250 million portfolio. Mr. Hibbert currently serves as the CFO of a non profit organization. Mr. Hibbert received a Bachelor of Science degree in Employee Relations from Michigan State University in 1981 and a Master in Biness Administration degree from the University of Texas at Atin in 1983.
- Chang Heng Fai Ambrose
-
长恒辉安布罗斯自2025年3月起担任公司董事。陈先生是银行和金融方面的专家，在这些行业拥有45年的经验。在过去的40年里，他重组了多个行业和国家的数字公司。
Chang Heng Fai Ambrose has served as a director of the Company since March 2025. Mr. Chan has over 45 years of experience in banking and finance and has led the restructuring of numero companies across multiple indtries and jurisdictions. Mr. Chan currently serves as Chairman and/or Chief Executive Officer of several public companies, including Alset Inc., Alset International Limited and HWH International Inc., and has served on the boards of numero U.S., Hong Kong, Singapore and Atralian public companies. - 长恒辉安布罗斯自2025年3月起担任公司董事。陈先生是银行和金融方面的专家，在这些行业拥有45年的经验。在过去的40年里，他重组了多个行业和国家的数字公司。
- Chang Heng Fai Ambrose has served as a director of the Company since March 2025. Mr. Chan has over 45 years of experience in banking and finance and has led the restructuring of numero companies across multiple indtries and jurisdictions. Mr. Chan currently serves as Chairman and/or Chief Executive Officer of several public companies, including Alset Inc., Alset International Limited and HWH International Inc., and has served on the boards of numero U.S., Hong Kong, Singapore and Atralian public companies.
高管简历
中英对照 | 中文 | 英文- Frank D. Heuszel
FrankD.Heuszel自2018年7月30日起担任公司董事，并于2018年7月至2019年4月担任公司审计委员会主席。截至2020年10月28日，他自2019年4月17日起担任公司首席执行官兼临时首席财务官。从那时起，他只担任公司的首席执行官和董事，由于他的执行管理、教育和运营经验，他在多个行业的广泛的战略、业务、周转和监管事务方面拥有丰富的专业知识。在加入DSS之前，Heuszel先生在商业银行有着非常成功的职业生涯。在超过35年的时间里，Heuszel在主要的美国和国际银行组织担任许多高级执行职位。作为一名银行家，Heuszel先生曾担任总法律顾问、特殊资产总监、信贷官、首席财务官和审计员。Heuszel先生还经营着一家成功的法律事务所，专注于诉讼，公司重组，并购和收款。除了是一名律师和执行经理，Heuszel先生还是一名退休的注册会计师，以及一名注册内部审计师。Heuszel先生毕业于德克萨斯大学奥斯汀分校（University of Texas at Austin）和休斯顿南德克萨斯法学院（South Texas College of Law）。
Frank D. Heuszel has served as a member of Impact's board of directors since 2020 and served as the company's President until the 2025 promotion. Prior to becoming the CEO of Impact, Mr. Heuszel served as the Chief Executive Officer of DSS, Inc. ("DSS"), a NYSE:American publicly traded company. In that role he managed the strategic direction, growth, day to day operations, and governance of the New York based multinational company operating binesses in biohealth and bioscience, healthcare, securities trading and management platforms, blockchain technology, direct marketing, real estate, alternative energy, brand protection technology and securitized digital assets, with offices in Hoton, Tx., and W. Henreitta, NY. Mr. Heuszel became DSS's Chief Executive Officer and Interim Chief Financial Officer in April 2019. He served as a member of DSS's board of directors from July 2018 until his resignation in Augt 2024 that allod him to spearhead Impact BioMedical's growth and IPO. Heuszel has extensive expertise in a wide array of strategic, biness, turnaround, and regulatory matters across several indtries as a result of his executive management, educational, and operational experience. Prior to joining DSS, Mr. Heuszel had a very successful career in commercial banking. For over 40+ years, Heuszel served in many senior executive roles with major and international banking organizations. As a banker, Mr. Heuszel has served as General Counsel, Director of Special Assets, Senior Credit Officer, Chief Financial Officer, Controller, Senior Lender, and Director of Internal Audit. Mr. Heuszel also operates a successful law practice foced on the regulation and operation of banks, management of bank litigation, corporate restructurings, and mergers and acquisitions. In addition to being an attorney and executive manager, Mr. Heuszel is also a Certified Public Accountant (retired), and a Certified Internal Auditor (retired), and Certified Trt and Financial Advisor. Mr. Heuszel also currently serves as a director of a Texas community bank, Herring Bank of Amarillo, Texas since May 2022, where he serves upon several Board Committees, including the Audit Committee which he is the Chairman. He also serves on the Board of Herring Bancorp, Inc., where he also serves on multiple board committees, including Chair of the Audit Committee. Frank D. Heuszel was born in Branson, Missi, graduated from the University of Texas at Atin from the McCombs School of Biness in 1979 and received his Doctor of Jurisprudence with honors from South Texas College of Law in 1990. Frank received his certification as a Certified Public Accountant and as a Certified Internal Auditor in 1985 and certified as Certified Trt and Financial Advisor (CTFA) in 2025. Mr. Heuszel is also a member of the Texas State Bar, the Hoton Bar Association, and the State Bar of Texas Bankruptcy Section.- FrankD.Heuszel自2018年7月30日起担任公司董事，并于2018年7月至2019年4月担任公司审计委员会主席。截至2020年10月28日，他自2019年4月17日起担任公司首席执行官兼临时首席财务官。从那时起，他只担任公司的首席执行官和董事，由于他的执行管理、教育和运营经验，他在多个行业的广泛的战略、业务、周转和监管事务方面拥有丰富的专业知识。在加入DSS之前，Heuszel先生在商业银行有着非常成功的职业生涯。在超过35年的时间里，Heuszel在主要的美国和国际银行组织担任许多高级执行职位。作为一名银行家，Heuszel先生曾担任总法律顾问、特殊资产总监、信贷官、首席财务官和审计员。Heuszel先生还经营着一家成功的法律事务所，专注于诉讼，公司重组，并购和收款。除了是一名律师和执行经理，Heuszel先生还是一名退休的注册会计师，以及一名注册内部审计师。Heuszel先生毕业于德克萨斯大学奥斯汀分校（University of Texas at Austin）和休斯顿南德克萨斯法学院（South Texas College of Law）。
- Frank D. Heuszel has served as a member of Impact's board of directors since 2020 and served as the company's President until the 2025 promotion. Prior to becoming the CEO of Impact, Mr. Heuszel served as the Chief Executive Officer of DSS, Inc. ("DSS"), a NYSE:American publicly traded company. In that role he managed the strategic direction, growth, day to day operations, and governance of the New York based multinational company operating binesses in biohealth and bioscience, healthcare, securities trading and management platforms, blockchain technology, direct marketing, real estate, alternative energy, brand protection technology and securitized digital assets, with offices in Hoton, Tx., and W. Henreitta, NY. Mr. Heuszel became DSS's Chief Executive Officer and Interim Chief Financial Officer in April 2019. He served as a member of DSS's board of directors from July 2018 until his resignation in Augt 2024 that allod him to spearhead Impact BioMedical's growth and IPO. Heuszel has extensive expertise in a wide array of strategic, biness, turnaround, and regulatory matters across several indtries as a result of his executive management, educational, and operational experience. Prior to joining DSS, Mr. Heuszel had a very successful career in commercial banking. For over 40+ years, Heuszel served in many senior executive roles with major and international banking organizations. As a banker, Mr. Heuszel has served as General Counsel, Director of Special Assets, Senior Credit Officer, Chief Financial Officer, Controller, Senior Lender, and Director of Internal Audit. Mr. Heuszel also operates a successful law practice foced on the regulation and operation of banks, management of bank litigation, corporate restructurings, and mergers and acquisitions. In addition to being an attorney and executive manager, Mr. Heuszel is also a Certified Public Accountant (retired), and a Certified Internal Auditor (retired), and Certified Trt and Financial Advisor. Mr. Heuszel also currently serves as a director of a Texas community bank, Herring Bank of Amarillo, Texas since May 2022, where he serves upon several Board Committees, including the Audit Committee which he is the Chairman. He also serves on the Board of Herring Bancorp, Inc., where he also serves on multiple board committees, including Chair of the Audit Committee. Frank D. Heuszel was born in Branson, Missi, graduated from the University of Texas at Atin from the McCombs School of Biness in 1979 and received his Doctor of Jurisprudence with honors from South Texas College of Law in 1990. Frank received his certification as a Certified Public Accountant and as a Certified Internal Auditor in 1985 and certified as Certified Trt and Financial Advisor (CTFA) in 2025. Mr. Heuszel is also a member of the Texas State Bar, the Hoton Bar Association, and the State Bar of Texas Bankruptcy Section.
- Todd D. Macko
Todd D.Macko被提升为临时首席财务官，于2020年10月28日生效。Macko先生此前曾担任该公司的财务Vice President。作为财务Vice President，Macko先生的职责包括在财务和监管报告的所有方面协助安保部的临时首席财务官。此外，他的职责包括公司会计和财务团队的日常管理以及指导和改进会计、报告、审计、税务活动的财务领导。在担任公司财务Vice President之前，Macko先生于2019年1月加入DSS的全资子公司Premier Packaging Corporation，担任其财务Vice President。Macko先生是一名注册会计师，拥有超过25年的公共和企业财务管理，业务领导和企业战略经验。在加入公司之前，Macko先生于2015年11月至2019年1月担任食品和饮料行业领先的定制配料制造商Baldwin Richardson Foods的公司财务总监。在此之前，麦科先生曾担任Outdoor Group，LLC.、Genesis Vision，Inc.、Complear Partners，Inc.和Level3Communications，Inc.的财务总监。Macko先生在Rochester Institute of Technology获得会计学理学学士学位。
Todd D. Macko has been Secretary and Treasurer of the Company since January 2021 and in May 2023 became Chief Financial Officer of the Company. Mr. Macko has served as the Chief Financial Officer of DSS since August 16, 2021. Mr. Macko previoly served as the Vice President of Finance of DSS. As the Vice President of Finance, Mr. Macko's responsibilities included assisting DSS's Interim Chief Financial Officer in all aspects of financial and regulatory reporting. In addition, his responsibilities included the day to day management of the Company's Accounting and Finance team and the financial leadership in the directing and improving of the accounting, reporting, audit, and tax activities. Prior to his role as Vice President of Finance for the Company, Mr. Macko joined the wholly owned subsidiary of DSS, Premier Packaging Corporation in January 2019, as its Vice President of Finance. Mr. Macko is a Certified Public Accountant with over 25 years of public and corporate financial management, biness leadership and corporate strategy. Mr. Macko brings a Wealth of experience with strengths in financial planning and analysis, biness process re engineering, budgeting, merger and acquisitions, financial reporting systems, project evaluation and treasury and capital management. Prior to joining the Company, Mr. Macko served as the Corporate Controller for Baldwin Richardson Foods, a leading ctom ingredients manufacturer for the food and beverage industry from November 2015 until January 2019. Prior to that, Mr. Macko served as the Controller for The Outdoor Group, LLC., Genesis Vision, Inc., Complemar Partners, Inc., and Level 3 Communications, Inc. Mr. Macko obtained his Bachelor of Science degree in Accounting from Rochester Institute of Technology.- Todd D.Macko被提升为临时首席财务官，于2020年10月28日生效。Macko先生此前曾担任该公司的财务Vice President。作为财务Vice President，Macko先生的职责包括在财务和监管报告的所有方面协助安保部的临时首席财务官。此外，他的职责包括公司会计和财务团队的日常管理以及指导和改进会计、报告、审计、税务活动的财务领导。在担任公司财务Vice President之前，Macko先生于2019年1月加入DSS的全资子公司Premier Packaging Corporation，担任其财务Vice President。Macko先生是一名注册会计师，拥有超过25年的公共和企业财务管理，业务领导和企业战略经验。在加入公司之前，Macko先生于2015年11月至2019年1月担任食品和饮料行业领先的定制配料制造商Baldwin Richardson Foods的公司财务总监。在此之前，麦科先生曾担任Outdoor Group，LLC.、Genesis Vision，Inc.、Complear Partners，Inc.和Level3Communications，Inc.的财务总监。Macko先生在Rochester Institute of Technology获得会计学理学学士学位。
- Todd D. Macko has been Secretary and Treasurer of the Company since January 2021 and in May 2023 became Chief Financial Officer of the Company. Mr. Macko has served as the Chief Financial Officer of DSS since August 16, 2021. Mr. Macko previoly served as the Vice President of Finance of DSS. As the Vice President of Finance, Mr. Macko's responsibilities included assisting DSS's Interim Chief Financial Officer in all aspects of financial and regulatory reporting. In addition, his responsibilities included the day to day management of the Company's Accounting and Finance team and the financial leadership in the directing and improving of the accounting, reporting, audit, and tax activities. Prior to his role as Vice President of Finance for the Company, Mr. Macko joined the wholly owned subsidiary of DSS, Premier Packaging Corporation in January 2019, as its Vice President of Finance. Mr. Macko is a Certified Public Accountant with over 25 years of public and corporate financial management, biness leadership and corporate strategy. Mr. Macko brings a Wealth of experience with strengths in financial planning and analysis, biness process re engineering, budgeting, merger and acquisitions, financial reporting systems, project evaluation and treasury and capital management. Prior to joining the Company, Mr. Macko served as the Corporate Controller for Baldwin Richardson Foods, a leading ctom ingredients manufacturer for the food and beverage industry from November 2015 until January 2019. Prior to that, Mr. Macko served as the Controller for The Outdoor Group, LLC., Genesis Vision, Inc., Complemar Partners, Inc., and Level 3 Communications, Inc. Mr. Macko obtained his Bachelor of Science degree in Accounting from Rochester Institute of Technology.
- Mark Suseck
Mark Suseck，自2023年8月起担任公司首席运营官。苏塞克先生在2020年至2023年期间担任DSS公司子公司DSS生物健康控股公司的首席运营官，领导公司战略、运营、许可、收购和商业化。从2021年到2022年，苏塞克担任Vivacitas Oncology Inc.的首席执行官，领导公司战略、临床开发、运营和融资。2018-2019年，苏塞克先生担任Helius Medical技术公司全球销售和营销副总裁。苏塞克先生在罗格斯大学获得经济学本科学位，辅修教育和哲学。他在密歇根大学商学院完成了行政管理课程。
Mark Suseck has served as Chief Operating Officer of the Company since August 2023. Mr. Suseck served as the chief operating officer of DSS BioHealth Holdings Inc., a subsidiary of DSS, Inc., from 2020 2023, where he led company strategy, operations, licensing, acquisitions and commercialization. From 2021 to 2022, Mr. Suseck served as the chief executive officer of Vivacitas Oncology Inc., where he led company strategy, clinical development, operations and financing. From 2018 2019, Mr. Suseck was vice president of global sales and marketing at Heli Medical Technologies Inc. Mr. Suseck received his undergraduate degree in economics from Rutgers University, with minors in education and philosophy. He completed the Executive Management Program in residence at the University of Michigan Biness School.- Mark Suseck，自2023年8月起担任公司首席运营官。苏塞克先生在2020年至2023年期间担任DSS公司子公司DSS生物健康控股公司的首席运营官，领导公司战略、运营、许可、收购和商业化。从2021年到2022年，苏塞克担任Vivacitas Oncology Inc.的首席执行官，领导公司战略、临床开发、运营和融资。2018-2019年，苏塞克先生担任Helius Medical技术公司全球销售和营销副总裁。苏塞克先生在罗格斯大学获得经济学本科学位，辅修教育和哲学。他在密歇根大学商学院完成了行政管理课程。
- Mark Suseck has served as Chief Operating Officer of the Company since August 2023. Mr. Suseck served as the chief operating officer of DSS BioHealth Holdings Inc., a subsidiary of DSS, Inc., from 2020 2023, where he led company strategy, operations, licensing, acquisitions and commercialization. From 2021 to 2022, Mr. Suseck served as the chief executive officer of Vivacitas Oncology Inc., where he led company strategy, clinical development, operations and financing. From 2018 2019, Mr. Suseck was vice president of global sales and marketing at Heli Medical Technologies Inc. Mr. Suseck received his undergraduate degree in economics from Rutgers University, with minors in education and philosophy. He completed the Executive Management Program in residence at the University of Michigan Biness School.